ArticleInvestigational new drugs2016

Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).

Amy Prawira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.